Alberta Investment Management Corp (AIMCo)’s ADMA Biologics ADMA Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio ADMA Stock Details ADMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-294,250	Closed	-$5.84M	–	570
2025 Q1	$5.84M	Buy	294,250 +44,557	+18%	+$771K	0.04%	259
2024 Q4	$4.28M	Hold	249,693	–	–	0.03%	304
2024 Q3	$4.99M	Sell	249,693 -252,749	-50%	-$3.93M	0.04%	233
2024 Q2	$5.62M	Buy	502,442 +41,668	+9%	+$350K	0.06%	196
2024 Q1	$3.04M	Hold	460,774	–	–	0.03%	329
2023 Q4	$2.08M	Buy	460,774 +112,831	+32%	+$417K	0.02%	418
2023 Q3	$1.25M	Sell	347,943 -7,145	-2%	-$27.5K	0.01%	571
2023 Q2	$1.31M	Buy	355,088 +332,815	+1,494%	+$1.23M	0.01%	664
2023 Q1	$73.7K	Buy	+22,273	New	+$77K	﹤0.01%	1209

Other funds holding ADMA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s ADMA Position: Q2 2025 in Review

Alberta Investment Management Corp (AIMCo) sold out of ADMA Biologics (ADMA) in Q2 2025, closing a stake of 294,250 shares — an estimated $5.84M sold.

Alberta Investment Management Corp (AIMCo) first reported a position in ADMA in Q1 2023 and held it in 9 quarters. The position peaked at $5.84M in Q1 2025. 368 funds tracked by Wall St. Rank hold ADMA as of Q2 2025.

Alberta Investment Management Corp (AIMCo) reported no remaining ADMA Biologics position as of Q2 2025 after selling out during the quarter.
Alberta Investment Management Corp (AIMCo) sold 294,250 ADMA Biologics shares in Q2 2025, an estimated $5.84M.
Alberta Investment Management Corp (AIMCo) first reported a position in ADMA Biologics in Q1 2023 and held it in 9 quarters.
Alberta Investment Management Corp (AIMCo)'s ADMA Biologics position peaked at $5.84M in Q1 2025.
368 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2025.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q2 2025, filed 8 Aug 2025.